Epithalon and Epitalon: Cell-Line Source Scope and Documentation Review

Research use only. It does not provide human or veterinary use, dosing, administration, safety, or outcome guidance.

Keep source terminology visible

The linked catalogue uses the term Epithalon. The checked paper uses Epitalon. Similar spelling is a search lead, not proof that a catalogue item, a paper’s test article, and a received batch have the same identity. Preserve the exact source term, plus any sequence, form, or preparation details the source reports.

Defined source: a cell-line study using Epitalon

Al-Dulaimi et al. (2025; PMID 40908429) report a cell-line study using the term Epitalon. The described systems include 21NT and BT474 breast-cancer cell lines, normal epithelial cells, and fibroblasts. The authors extracted DNA, RNA, and proteins, and used qPCR and immunofluorescence to assess reported telomere-related, hTERT, telomerase, and ALT measures.

The source is limited to its named material, cell systems, methods, and endpoints. This page does not repeat its dose-related, medical, or longevity interpretation. Nor does the paper identify or analytically verify a separate Epithalon product or batch.

How to record the comparison

Place the paper’s exact term and cell systems in the literature record. Place the product label, lot identifier, receipt date, and supplied documents in the received-material record. If a sequence or analytical field is missing from either record, mark it as unreported rather than filling it from spelling similarity.